Oxytrol approved for overactive bladder.
Wimett
Lynn
L
Department of Nursing, Regis University, Denver, CO, USA.
Laustsen
Gary
G
D000279:Administration, Cutaneous; D002986:Clinical Trials as Topic; D017277:Drug Approval; D006801:Humans; D008333:Mandelic Acids / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy* / Q000451:nursing; D014555:Urination Disorders / Q000188:drug therapy* / Q000451:nursing
D008333:Mandelic Acids; C005419:oxybutynin